Latest Close
$3.75
News
ADAG
Adagene Inc. News
This news view pulls recent coverage and headlines tied to ADAG.
1y Change
$1.93 (+106.04%)
Market Cap
$247,772,224.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
none
Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer
MarketBeat • May 19, 2026
Read articleAdagene to Participate in Two Upcoming Investor Conferences
GlobeNewswire • May 12, 2026
Read articleAdagene (ADAG) Partners With Incyte (INCY) to Evaluate Combination Therapy for Colorectal Cancer
Insider Monkey • Apr 20, 2026
Read articleAdagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
GlobeNewswire • Apr 17, 2026
Read articleAdagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board
GlobeNewswire • Apr 14, 2026
Read articleIncyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology Collaboration - Has The Bull Case Changed?
Simply Wall St. • Apr 5, 2026
Read article